Patient and Public Involvement in the Development of Healthcare Guidance: An Overview of Current Methods and Future Challenges

  • Ahmed Rashid
  • Victoria Thomas
  • Toni Shaw
  • Gillian Leng
Current Opinion

Abstract

Clinical guidelines and health technology assessments are valuable instruments to improve the quality of healthcare delivery and aim to integrate the best available evidence with real-world, expert context. The role of patient and public involvement in their development has grown in recent decades, and this article considers the international literature exploring aspects of this participation, including the integration of experiential and scientific knowledge, recruitment strategies, models of involvement, stages of involvement, and methods of evaluation. These developments have been underpinned by the parallel rise of public involvement and evidence-based medicine as important concepts in health policy. Improving the recruitment of guideline group chairs, widening evidence reviews to include patient preference studies, adapting guidance presentation to highlight patient preference points and providing clearer instructions on how patient organisations can submit their intelligence are emerging proposals that may further enhance patient and public involvement in their processes.

References

  1. 1.
    Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ Br Med J. 1999;318(7182):527–30.CrossRefGoogle Scholar
  2. 2.
    Grol R, Wensing M, Eccles M. Improving patient care: the implementation of change in clinical practice. New York: Elsevier Butterworth Heinemann; 2005.Google Scholar
  3. 3.
    Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS ONE. 2011;6(6):e20476.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jackson R, Feder G. Guidelines for clinical guidelines. BMJ. 1998;317(7156):427–8.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Clinical guidelines: using clinical guidelines. BMJ. 1999;318(7185):728.3.Google Scholar
  6. 6.
    Cavazza M, Jommi C. Stakeholders involvement by HTA organisations: why is so different? Health Policy. 2012;105(2–3):236–45.CrossRefPubMedGoogle Scholar
  7. 7.
    Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281(20):1900–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care. 2005;17:235–42.CrossRefPubMedGoogle Scholar
  9. 9.
    Knai C, Brusamento S, Legido-Quigley H, et al. Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe. Health Policy. 2012;107(2–3):157–67.CrossRefPubMedGoogle Scholar
  10. 10.
    Crawford MJ, Rutter D, Manley C, Weaver T, Bhui K, Fulop N, et al. Systematic review of involving patients in the planning and development of health care. BMJ. 2002;325:1263–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Boote J, Telford R, Cooper C. Consumer involvement in health research: a review and research agenda. Health Policy. 2002;61:213–36.CrossRefPubMedGoogle Scholar
  12. 12.
    Nilsen ES, Myrhaug HT, Johansen M, Oliver S, Oxman AD. Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Cochrane Database Syst Rev. 2006;3(3):CD004563.Google Scholar
  13. 13.
    Gagnon MP, Desmartis M, Lepage-Savary D, Gagnon J, St-Pierre M, Rhainds M, et al. Introducing patients’ and the public’s perspectives to health technology assessment: a systematic review of international experiences. Int J Technol Assess Health Care. 2011;27(1):31–42.CrossRefPubMedGoogle Scholar
  14. 14.
    Hailey D, Werkö S, Bakri R, Cameron A, Göhlen B, Myles S, et al. Involvement of consumers in health technology assessment activities by Inahta agencies. Int J Technol Assess Health Care. 2013;29(1):79–83.CrossRefPubMedGoogle Scholar
  15. 15.
    Kelson M, Akl EA, Bastian H, Cluzeau F, Curtis JR, Guyatt G, et al. Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):262–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Quennell P. Getting their say, or getting their way? Has participation strengthened the patient “voice” in the National Institute for Clinical Excellence? J Manag Med. 2001;15(3):202–19.CrossRefPubMedGoogle Scholar
  17. 17.
    Bastian H. Raising the standard: practice guidelines and consumer participation. Int J Qual Health Care. 1996;8(5):485–90.CrossRefPubMedGoogle Scholar
  18. 18.
    Roman BR, Feingold J. Patient-centered guideline development best practices can improve the quality and impact of guidelines. Otolaryngol Head Neck Surg. 2014;151(4):530–2.CrossRefPubMedGoogle Scholar
  19. 19.
    Tong A, Lopez-Vargas P, Howell M, Phoon R, Johnson D, Campbell D, et al. Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expect. 2012;15(4):410–23.CrossRefPubMedGoogle Scholar
  20. 20.
    Barham L. Public and patient involvement at the UK National Institute for Health and Clinical Excellence. Patient. 2011;4(1):1–10.CrossRefPubMedGoogle Scholar
  21. 21.
    Díaz Del Campo P, Gracia J, Blasco JA, Andradas E. A strategy for patient involvement in clinical practice guidelines: methodological approaches. BMJ Qual Saf. 2011;20(9):779–84.CrossRefPubMedGoogle Scholar
  22. 22.
    Facey KM, Hansen HP. Patient-focused HTAs. Int J Technol Assess Health Care. 2011;27(4):273–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Kelson M. The NICE patient involvement unit. Evid Based Healthc Public Health. 2005;9(4):304–7.CrossRefGoogle Scholar
  24. 24.
    Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA. 2008;300(4):436–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Bridges JF, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care. 2007;23(1):30–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Kelson M. Patient involvement in clinical guideline development–where are we now? J Clin Govern. 2001;9(4):169–74.Google Scholar
  27. 27.
    van Wersch A, Eccles M. Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme. Qual Health Care. 2001;10(1):10–6.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    van de Bovenkamp HM, Trappenburg MJ. Reconsidering patient participation in guideline development. Health Care Anal. 2009;17(3):198–216.CrossRefPubMedGoogle Scholar
  29. 29.
    Harding E, Pettinari CJ, Brown D, Hayward M, Taylor C. Service user involvement in clinical guideline development and implementation: learning from mental health service users in the UK. Int Rev Psychiatry. 2011;23(4):352–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Légaré F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Légaré J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Decis Making. 2011;31(6):E45–74.Google Scholar
  31. 31.
    Whitty JA. An international survey of the public engagement practices of health technology assessment organizations. Value Health. 2013;16(1):155–63.CrossRefPubMedGoogle Scholar
  32. 32.
    Pohontsch NJ, Herzberg H, Joos S, Welti F, Scherer M, Blozik E. The professional perspective on patient involvement in the development of quality indicators: a qualitative analysis using the example of chronic heart failure in the German health care setting. Patient Prefer Adher. 2015;22(9):151–9.Google Scholar
  33. 33.
    van de Bovenkamp HM, Zuiderent-Jerak T. An empirical study of patient participation in guideline development: exploring the potential for articulating patient knowledge in evidence-based epistemic settings. Health Expect. 2013. doi:10.1111/hex.12067.
  34. 34.
    Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    van der Ham AJ, Shields LS, van der Horst R, Broerse JE, van Tulder MW. Facilitators and barriers to service user involvement in mental health guidelines: lessons from the Netherlands. Adm Policy Ment Health. 2014;41(6):712–23.CrossRefPubMedGoogle Scholar
  36. 36.
    Lopes E, Street J, Carter D, Merlin T. Involving patients in health technology funding decisions: stakeholder perspectives on processes used in Australia. Health Expect. 2015. doi:10.1111/hex.12356.
  37. 37.
    Facey K, Boivin A, Gracia J, Hansen HP, Lo Scalzo A, Mossman J, et al. Patients’ perspectives in health technology assessment: a route to robust evidence and fair deliberation. Int J Technol Assess Health Care. 2010;26(3):334–40.CrossRefPubMedGoogle Scholar
  38. 38.
    Boivin A, Currie K, Fervers B, Gracia J, James M, Marshall C, et al. Patient and public involvement in clinical guidelines: international experiences and future perspec Qual Saf Health Care. 2010;19(5):e22.Google Scholar
  39. 39.
    Chong CA, Chen IJ, Naglie G, Krahn MD. How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med. 2009;24(8):977–82.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Quennell P. Getting a word in edgeways? Patient group participation in the appraisal process of the National Institute for Clinical Excellence. Clin Govern Int J. 2003;8(1):39–45.CrossRefGoogle Scholar
  41. 41.
    Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA. 2013;310(23):2503–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Boivin A, Green J, van der Meulen J, Légaré F, Nolte E. Why consider patients’ preferences? A discourse analysis of clinical practice guideline developers. Med Care. 2009;47(8):908–15.CrossRefPubMedGoogle Scholar
  43. 43.
    Gauvin FP, Abelson J, Giacomini M, Eyles J, Lavis JN. “It all depends”: conceptualizing public involvement in the context of health technology assessment agencies. Soc Sci Med. 2010;70(10):1518–26.CrossRefPubMedGoogle Scholar
  44. 44.
    Bombard Y, Abelson J, Simeonov D, Gauvin FP. Eliciting ethical and social values in health technology assessment: a participatory approach. Soc Sci Med. 2011;73(1):135–44.CrossRefPubMedGoogle Scholar
  45. 45.
    Clarke J, Chuter A. The BASHH public panel: climbing the ladder of involvement. Sex Transm Infect. 2014;90(2):83.CrossRefPubMedGoogle Scholar
  46. 46.
    Arnstein SR. A ladder of citizen participation. J Am Inst Plan. 1969;35(4):216–24.CrossRefGoogle Scholar
  47. 47.
    Syrett K. Deconstructing deliberation in the appraisal of medical technologies: NICEly does it? Mod Law Rev. 2006;69(6):869–94.CrossRefGoogle Scholar
  48. 48.
    Abelson J, Bombard Y, Gauvin FP, Simeonov D, Boesveld S. Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care. 2013;29(3):282–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Pittens CA, Vonk Noordegraaf A, van Veen SC, Anema JR, Huirne JA, Broerse JE. The involvement of gynaecological patients in the development of a clinical guideline for resumption of (work) activities in the Netherlands. Health Expect. 2013. doi:10.1111/hex.12121.
  50. 50.
    Moreira T. Understanding the role of patient organisations in health technology assessment. Health Expect. 2014. doi:10.1111/hex.12325.
  51. 51.
    Gauvin FP, Abelson J, Giacomini M, Eyles J, Lavis JN. Moving cautiously: public involvement and the health technology assessment community. Int J Technol Assess Health Care. 2011;27(1):43–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Boivin A, Lehoux P, Lacombe R, Burgers J, Grol R. Involving patients in setting priorities for healthcare improvement: a cluster randomized trial. Implement Sci. 2014;20(9):24.CrossRefGoogle Scholar
  53. 53.
    Kötter T, Schaefer FA, Scherer M, Blozik E. Involving patients in quality indicator development—a systematic review. Patient Prefer Adher. 2013;7:259–68.Google Scholar
  54. 54.
    Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf. 2016;25(8):626–32.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Ahmed Rashid
    • 1
  • Victoria Thomas
    • 1
  • Toni Shaw
    • 1
  • Gillian Leng
    • 1
  1. 1.National Institute for Health and Care Excellence (NICE)LondonUK

Personalised recommendations